Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 10, 2026 2 hours, 23 minutes ago
Medical News: A simple blood test taken at hospital admission may hold powerful clues about survival after a severe heart attack, according to a new study that is reshaping how doctors assess risk in emergency settings.
Simple inflammation test may reveal hidden danger after heart attacks
Researchers have found that levels of C-reactive protein (CRP), a marker of inflammation in the body, can strongly predict whether patients suffering from ST-segment elevation myocardial infarction (STEMI) - a life-threatening type of heart attack - are likely to survive in both the short and long term.
Why Inflammation Matters in Heart Attacks
When a heart attack occurs, the body launches an intense inflammatory response to repair damaged heart tissue. While this process is necessary, excessive inflammation can worsen injury, weaken heart function, and increase the risk of death.
CRP is produced by the liver in response to inflammation and rises quickly after a heart attack. Because it is inexpensive and widely available, scientists have long suspected it could help doctors better predict patient outcomes - but until now, its exact risk thresholds were unclear.
Inside the Study
The research team from the Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, and University Hospital Salzburg in Austria analyzed 958 patients admitted with STEMI between 2018 and 2020.
Patients were divided into four groups based on their CRP levels at admission:
-Less than 5 mg/dL
-5 to 9.9 mg/dL
-10 to 15 mg/dL
-Above 15 mg/dL
The team then tracked survival over multiple time periods - 30 days, 90 days, 6 months, and up to five years.
Clear Link Between CRP and Survival
The findings revealed a striking pattern: the higher the CRP level, the worse the survival outcome.
Patients with CRP levels above 15 mg/dL had the highest risk of death. In fact, they were more than four times more likely to die within 30 days compared to those with low CRP levels. This elevated risk remained significant even years after the heart attack.
Kaplan–Meier survival curves (shown in the study’s charts on page 6) clearly illustrate this trend, with survival steadily declining as CRP levels rise.
Hidden Danger in “Moderate” Levels
One of the most important discoveries was that risk is not the same for everyone. This
Medical News report highlights that certain groups - including younger patients, smokers, and those with diabetes—face serious risks even at much lower CRP levels.
For example:
-Diabetic patients showed increased mortality risk at CRP levels as low as 5–6 mg/dL
-Younger individuals faced higher risk at around 9&
amp;ndash;10 mg/dL
-Smokers and patients with delayed treatment also showed heightened sensitivity
This means that what might appear to be a “moderate” CRP level could actually signal danger in specific populations.
What the Numbers Really Show
The study also used statistical tools to measure how well CRP predicts outcomes. While CRP showed moderate overall accuracy, its predictive power was significantly stronger in high-risk subgroups.
Importantly, the commonly used “one-size-fits-all” threshold of around 11–15 mg/dL may not be appropriate for everyone. Instead, personalized thresholds based on patient characteristics could improve early risk detection.
Why This Matters for Patients
These findings could have immediate clinical impact. Since CRP testing is already routine, doctors could use it more effectively to identify high-risk patients earlier and tailor treatment strategies accordingly.
For example, patients with elevated CRP might benefit from closer monitoring, more aggressive therapies, or even future anti-inflammatory treatments aimed at reducing heart damage.
Conclusion
The study provides compelling evidence that inflammation plays a central role in determining survival after a heart attack and that CRP is a powerful, accessible tool for measuring that risk. Importantly, it challenges the traditional approach of using uniform thresholds and instead supports a more personalized strategy, where even modest increases in CRP are taken seriously in vulnerable groups. By recognizing these differences, healthcare providers may be able to intervene earlier and improve survival outcomes, potentially saving lives through better risk stratification and targeted care.
The study findings were published in the peer reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/15/8/2864
For the latest research on heart attack, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/cardiology
Medical-News-Blood-Marker-Predicts-Death-Risk-After-Heart-Attack
Simple inflammation test may reveal hidden danger after heart attacks
Share
Tweet
Share
